News | November 19, 2018

Urine Tests Can Show Patient Compliance With Blood Pressure Medication

Doctors from Leicester’s Hospitals and the University of Leicester show simple process may save NHS millions.

A urine test can show patient compliance with taking their hypertension, high blood pressure, medications.

November 16, 2018 — A research team led by scientists and doctors in Leicester and the Netherlands has shown that a urine test to measure whether patients are taking their medications will save the the U.K. National Health Service (NHS) money.

The research, published in the American Heart Association (AHA) journal Hypertension, was conducted in collaboration between the University of Leicester, Leicester’s Hospitals and University of Groningen, Netherlands.

Hypertension affects nearly one third of the population. Between 30 and 50 percent of patients with hypertension do not take all their medications as prescribed. It is estimated that this non-adherence costs the NHS millions of pounds in managing poor health outcomes and ordering costly tests to find out why patients’ blood pressure is not reduced.

The team led by Dr. Pankaj Gupta and Dr. Prashanth Patel, researchers based at the University of Leicester and Leicester’s Hospitals, has developed an innovative screening test which can detect non-adherence for 40 of the most commonly used blood pressure medications, all from a single urine sample. They have previously shown that using the test has positive results with blood pressure dropping by around 20 points (the equivalent of 2 new medications) once the results of the tests were discussed with non-adherent patients.
 
This study builds on from the previous research by modeling the health economics of using the test in patients with hypertension. The new study shows that performing the urine test would not only lead to improvements in the care of people with hypertension, but that it is also highly likely to be cost-effective. 

Using the best available data, the modelling predicts that in a cohort of 10,000, 65-year-old male hypertensive patients, using the urine test would save £495 per person screened, and prevent more than 500 heart attacks and 300 strokes. This is because non-adherence to prescribed hypertension drugs has been shown to correlate with a higher risk of cardiovascular events. The savings are thought to be even greater for younger hypertensive patients.

“Clinically we know that the urine test is very useful in patient care," said Gupta, the senior co-author of the paper from the University of Leicester’s Department of Cardiovascular Sciences and co-director of the National Centre for Drug Adherence Testing (NCAT) based at Leicester’s Hospitals. "The new 2018 European Society of Cardiology (ESC) and European Society of Hypertension (ESH) Guidelines have also recently supported the use of this novel test to assess non-adherence. We are very pleased to show that urine biochemical screening is extremely cost-effective and hence we can now recommend its wider adoption.” 

“Non-adherence to prescribed medications not only costs the NHS huge amounts of money, it also leads to adverse outcomes for patients. Our novel biochemical test is robust and simple to use in busy clinics," said Patel, co-author of the paper, Co-Director of NCAT and Honorary Senior Lecturer at the University of Leicester.

The urine test was established in 2011 and NCAT receives samples from around 33 NHS hospitals across the U.K. It is foreseen that with the new ESC-ESH guidelines and results of this study the use of this test will be adopted by more hospitals and GP practices in the U.K. and abroad.

“Non-adherence is a major problem globally in people with chronic conditions such as hypertension, diabetes and heart disease," said Kamlesh Khunti, professor of primary care diabetes and vascular medicine at University of Leicester, director of the National Institute for Health Research (NIHR) CLAHRC East Midlands and a study co-author. "The aging population means that greater numbers of people are living with more than one chronic condition, so taking more tablets, which is leading to poor adherence. This study for the first time shows that a targeted simple assessment of people who are likely to be non-adherent and then intervening would lead to improved outcomes that are cost-effective for the NHS.” 

The paper, “Cost-utility of an objective biochemical measure to improve adherence to antihypertensive treatment”, was published in Hypertension in October 2018.

 

Related Content

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the en
heart disease image
News | Cardiac Diagnostics | December 18, 2019
December 18, 2019 — In their latest report, “...
FDA Warns Troponin Tests Impacted by Biotin Dietary Supplement
Feature | Cardiac Diagnostics | November 05, 2019 | Dave Fornell, Editor
November 5, 2019 — The U.S.
Videos | Cardiac Diagnostics | October 29, 2019
Doctor Clyde Yancy was a keynote speaker and said doctors need to check their assumptions about patients at the door...
79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event

79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event. Image courtesy of University Hospitals.

News | Cardiac Diagnostics | October 16, 2019
Health and wellness screenings are more than just nice events for the community – they can save lives. A Mentor, Ohio,...
Pesticide Exposure May Increase Heart Disease and Stroke Risk

Image courtesy of zefe wu from Pixabay

News | Cardiac Diagnostics | October 15, 2019
On-the-job exposure to high levels of pesticides raised the risk of heart disease and stroke in a generally healthy...
World Heart Federation Launches Global Roadmap on Cardiovascular Disease Prevention Among Diabetics
News | Cardiac Diagnostics | September 04, 2019
At the European Society of Cardiology (ESC) Congress 2019 together with the World Congress of Cardiology, the World...
Insomnia Tied to Higher Risk of Heart Disease and Stroke

Image courtesy of the American Heart Association

News | Cardiac Diagnostics | August 19, 2019
People suffering from insomnia may have an increased risk of coronary artery disease, heart failure and stroke,...